From: The Epoch Times
Health Canada 's approval last July of a vaccine that protects women from a common from of cervical cancer may have been premature, say experts.
Canada's record for treatment of cervical cancer is adequate, they say, and fast-tracking Gardasil, a vaccine for Human Papilloma Virus (HPV), isn't the way to go. $300 million has been allotted to the vaccine program from the recent federal budget.
But health professionals are questioning the necessity of a HPV vaccine in countries like Canada , which have successful comprehensive cervical screening programs.
04/19/07
Latest Articles
About Us News & Articles Resources Your Health Connect With Us
© 2012 Canadian Women's Health Network.

The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.
